Pels EGM, Aarnoutse EJ, Leinders S, et al. Stability of a chronic implanted brain-computer interface in late-stage amyotrophic lateral sclerosis. Clin Neurophysiol 2019;130:1798-1803. Crossref ...

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease in the US and Charcot’s disease in Europe, is a progressive neurodegenerative disorder affecting motor neurons in the ...

Wenyan Li, Jinqi Liu and Wenting Li et al. Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery. Acta Materia Medica. 2025.

About Amyotrophic Lateral Sclerosis (ALS) ALS, also known as Lou Gehrig’s disease, is a fatal degenerative neurologic disorder that affects more than 55,000 people in the United States and Europe.

In April 2025, NEJM Evidence highlighted a study of Parmar's technology for the treatment of ALS, where multiple infusions led to improvement in patients' function decline. In May 2024, the ...